Needham Investment Management LLC Tekla Life Sciences Investors Transaction History

Needham Investment Management LLC

$1.04 Billion
Q1 2024

A detailed history of Needham Investment Management LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Needham Investment Management LLC holds 330,229 shares of HQL stock, worth $4.66 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

330,229

Previous 313,792 5.24%

Holding current value

$4.66 Million

Previous $4.22 Million 6.58%

% of portfolio

0.43%

Previous 0.55%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.38 - $14.33 $219,927 - $235,542	16,437 Added 5.24%	330,229 $4.5 Million
Q3 2023 Nov 13, 2023	BUY	$12.38 - $13.69 $97,331 - $107,630	7,862 Added 2.57%	313,792 $3.91 Million
Q2 2023 Aug 11, 2023	BUY	$13.13 - $14.17 $90,570 - $97,744	6,898 Added 2.31%	305,930 $4.14 Million
Q4 2022 Feb 13, 2023	SELL	$13.55 - $15.23 $2.05 Million - $2.3 Million	-150,968 Reduced 33.55%	299,032 $4.25 Million
Q2 2021 Aug 16, 2021	SELL	$19.14 - $21.44 $478,500 - $536,000	-25,000 Reduced 5.26%	450,000 $9.65 Million

Q4 2020 Feb 16, 2021	SELL	$16.8 - $20.21 $168,000 - $202,100	-10,000 Reduced 2.06%	475,000 $9.38 Million
Q3 2020 Nov 16, 2020	SELL	$16.71 - $19.06 $83,550 - $95,300	-5,000 Reduced 1.02%	485,000 $8.53 Million
Q2 2020 Aug 14, 2020	SELL	$14.22 - $18.38 $71,100 - $91,900	-5,000 Reduced 1.01%	490,000 $8.8 Million
Q1 2020 May 15, 2020	SELL	$12.22 - $17.99 $89,926 - $132,388	-7,359 Reduced 1.46%	495,000 $7.42 Million
Q3 2019 Nov 14, 2019	SELL	$15.09 - $17.09 $264,075 - $299,075	-17,500 Reduced 3.37%	502,359 $7.59 Million
Q2 2019 Aug 14, 2019	SELL	$15.54 - $17.47 $194,250 - $218,375	-12,500 Reduced 2.35%	519,859 $8.76 Million
Q1 2019 May 15, 2019	SELL	$15.5 - $17.9 $93,000 - $107,399	-6,000 Reduced 1.11%	532,359 $9.12 Million
Q3 2018 Nov 14, 2018	SELL	$18.89 - $20.49 $63,583 - $68,969	-3,366 Reduced 0.62%	538,359 $11 Million
Q1 2018 May 15, 2018	BUY	$18.92 - $21.52 $37,840 - $43,040	2,000 Added 0.37%	541,725 $10.4 Million
Q4 2017 Feb 14, 2018	SELL	$18.31 - $22.24 $193,738 - $235,321	-10,581 Reduced 1.92%	539,725 $10.6 Million
Q3 2017 Nov 14, 2017	SELL	$20.12 - $21.88 $50,300 - $54,700	-2,500 Reduced 0.45%	550,306 $11.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	552,806	552,806 $11.5 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

8.51M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Needham Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Needham Investment Management LLC with notifications on news.

Account

Needham Investment Management LLC Tekla Life Sciences Investors Transaction History